valproic acid has been researched along with 3-methyladenine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Y; Dai, XY; Guan, QC; Guan, Y; Kong, W; Wang, X; Xu, MJ; Zhao, MM; Zhao, Y; Zhu, WG | 1 |
| Doi, S; Doi, T; Kawaoka, K; Masaki, T; Nakashima, A; Ueno, T; Yamada, K | 1 |
| Li, XX; Weng, LH; Wu, JY; Xu, Y; Yu, LJ; Zhang, Y | 1 |
3 other study(ies) available for valproic acid and 3-methyladenine
| Article | Year |
|---|---|
Phosphate-induced autophagy counteracts vascular calcification by reducing matrix vesicle release.
Topics: Adenine; Alkaline Phosphatase; Amino Acid Chloromethyl Ketones; Animals; Antioxidants; Autophagy; Autophagy-Related Protein 5; Caspase Inhibitors; Cattle; Cells, Cultured; Disease Models, Animal; Kidney Failure, Chronic; Metalloporphyrins; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphates; Proteins; Rats; RNA Interference; Secretory Vesicles; Sodium-Phosphate Cotransporter Proteins, Type III; Superoxide Dismutase; Time Factors; Transfection; Valproic Acid; Vascular Calcification | 2013 |
Valproic acid attenuates renal fibrosis through the induction of autophagy.
Topics: Actins; Adenine; Animals; Autophagy; Cell Line; Collagen Type I; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Epithelial Cells; Fibroblasts; Fibrosis; Kidney; Kidney Diseases; Male; Mice, Inbred C57BL; Microtubule-Associated Proteins; Rats; Transforming Growth Factor beta1; Ureteral Obstruction; Valproic Acid | 2017 |
Valproic acid protects against MPP
Topics: 1-Methyl-4-phenylpyridinium; Adenine; Apoptosis; Autophagy; Cell Line, Tumor; Cell Survival; Humans; Macrolides; Mitochondria; Neuroprotective Agents; Parkinson Disease; Reactive Oxygen Species; Valproic Acid | 2017 |